Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study

scientific article published on 01 June 1988

Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00320285
P953full work available at URLhttp://link.springer.com/article/10.1007/BF00320285/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF00320285
http://link.springer.com/content/pdf/10.1007/BF00320285.pdf
P698PubMed publication ID3382760

P2093author name stringE. Ferrari
G. Grignani
G. Gamba
L. Pacchiarini
S. B. Solerte
N. Montani
P2860cites workThe pathogenesis of atherosclerosis (first of two parts)Q33492794
Comparison of lipoprotein analysis by agarose gel and paper electrophoresis with analytical ultracentrifugationQ38487351
New concepts about the pathogenesis of atherosclerosis in diabetes mellitusQ40211452
Hematologic alterations in diabetes mellitusQ40299727
Activators and inhibitors of the fibrinolytic system in maturity-onset diabetes mellitus without thromboembolic manifestationsQ41589510
The determination of plasma fibrinogen by the clot-weight methodQ42287058
Quantitative determination of serum triglycerides by the use of enzymesQ43418524
In vitro injury of porcine aortic endothelial cells by very-low-density lipoproteins from diabetic rat serum.Q50933533
Hypertriglyceridaemia and hypercoagulabilityQ51647241
High glucose concentrations do not influence replication and prostacyclin release of human endothelial cells.Q54695432
High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitusQ66847965
Determination of the glycosylated hemoglobins (HB AI) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitusQ67377704
Enzymatic determination of total serum cholesterolQ69744405
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarctionQ69973450
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseQ70309305
On the regulation and control of fibrinolysis. Edward Kowalski Memorial LectureQ70538450
Platelets and diabetes mellitusQ70596712
Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrationsQ70596936
Glucose inhibits replication of cultured human endothelial cellsQ70599999
Effect of cholesterol on production of thromboxane b2 by platelets in vitroQ71128180
Fibrinogen as a risk factor for stroke and myocardial infarctionQ71438059
Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complicationsQ71579801
Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathyQ72380557
Haemostatic function and cardiovascular death: early results of a prospective studyQ72423400
Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathyQ72838494
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesQ72902854
Vascular disease and serum lipids in diabetes mellitus. Observations over thirty years (1931-1961)Q76430984
P433issue6
P407language of work or nameEnglishQ1860
P921main subjecthemostasisQ487937
P304page(s)257-260
P577publication date1988-06-01
P1433published inBlutQ27709414
P1476titleHaemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study
P478volume56

Search more.